• Cloudbreak Pharma relocated its principal place of business in Hong Kong effective Nov. 13, 2026.
• The new office is at Suite 2006, 20th Floor, Tower 1, The Gateway, Harbour City, Kowloon, Hong Kong.
• Share trading remains suspended until further notice under Securities and Futures Commission direction, effective 9 a.m. Sept. 10, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cloudbreak Pharma Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261113-12412656), on November 13, 2026, and is solely responsible for the information contained therein.